checkAd

    DGAP-Adhoc  188  0 Kommentare LANXESS Aktiengesellschaft: LANXESS signs contract to acquire Emerald Kalama Chemical

    DGAP-Ad-hoc: LANXESS Aktiengesellschaft / Key word(s): Mergers & Acquisitions/Takeover
    LANXESS Aktiengesellschaft: LANXESS signs contract to acquire Emerald Kalama Chemical

    14-Feb-2021 / 00:42 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Ad hoc according to Art. 17 paragraph 1 MMVO

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Lanxess AG!
    Long
    25,50€
    Basispreis
    0,20
    Ask
    × 13,48
    Hebel
    Short
    28,84€
    Basispreis
    0,21
    Ask
    × 12,83
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    LANXESS signs contract to acquire Emerald Kalama Chemical

    Cologne, February 14, 2021 - Specialty chemicals company LANXESS signed an agreement to acquire US-based Emerald Kalama Chemical from affiliates of American Securities LLC. Emerald Kalama Chemical is one of the leading global manufacturers of specialty chemicals especially for the consumer segment.

    Emerald Kalama employs worldwide approximately 500 employees and runs three production sites. The company reported 2020 sales of around USD 425 million and EBITDA pre exceptionals of approximately USD 90 million. Around 45 percent of its turnover is generated in North America.

    The enterprise value amounts to USD 1,075 million. The transaction will be financed by LANXESS existing liquidity. Closing of the transaction is anticipated in the second half of 2021 and subject to the approval of the relevant regulatory authorities.

    By acquiring Emerald Kalama Chemical, LANXESS strengthens its specialty chemical portfolio especially in the Consumer Protection segment and would materially expand into the growth markets food and animal nutrition.

    Cologne, February 14, 2021

    Forward-Looking Statements
    This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.


    Contact:
    André Simon

    LANXESS AG
    Head of Investor Relations

    Kennedyplatz 1
    50569 Köln, Deutschland
    Telefon: +49 221 8885-3494
    Fax: +49 221 8885-4944
    E-Mail: andre.simon@lanxess.com

    14-Feb-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de


    Language: English
    Company: LANXESS Aktiengesellschaft
    Kennedyplatz 1
    50569 Cologne
    Germany
    Phone: +49 (0)221 8885-3494
    Fax: +49 (0)221 8885-4944
    E-mail: ir@lanxess.com
    Internet: www.lanxess.com
    ISIN: DE0005470405
    WKN: 547040
    Indices: MDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1167850

     
    End of Announcement DGAP News Service

    1167850  14-Feb-2021 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1167850&application_name=news&site_id=wallstreet

    Lesen Sie auch



    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc LANXESS Aktiengesellschaft: LANXESS signs contract to acquire Emerald Kalama Chemical DGAP-Ad-hoc: LANXESS Aktiengesellschaft / Key word(s): Mergers & Acquisitions/Takeover LANXESS Aktiengesellschaft: LANXESS signs contract to acquire Emerald Kalama Chemical 14-Feb-2021 / 00:42 CET/CEST Disclosure of an inside information acc. to …

    Schreibe Deinen Kommentar

    Disclaimer